1-2 of 2
Margaret T. Kasner
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Single-Cell Pharmacodynamic Monitoring of S6 Ribosomal Protein Phosphorylation in AML Blasts during a Clinical Trial Combining the mTOR Inhibitor Sirolimus and Intensive Chemotherapy

Available to Purchase
Alexander E. Perl, Margaret T. Kasner, Doris Shank, Selina M. Luger, Martin Carroll
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (6): 1716–1725.
https://doi.org/10.1158/1078-0432.CCR-11-2346
Published: 14 March 2012
View articletitled, Single-Cell Pharmacodynamic Monitoring of S6 Ribosomal Protein Phosphorylation in AML Blasts during a Clinical Trial Combining the mTOR Inhibitor Sirolimus and Intensive Chemotherapy
Open the PDF for Single-Cell Pharmacodynamic Monitoring of S6 Ribosomal Protein Phosphorylation in AML Blasts during a Clinical Trial Combining the mTOR Inhibitor Sirolimus and Intensive Chemotherapy in another window
Includes: Supplementary data
Journal Articles

A Phase I Study of the Mammalian Target of Rapamycin Inhibitor Sirolimus and MEC Chemotherapy in Relapsed and Refractory Acute Myelogenous Leukemia

Available to Purchase
Alexander E. Perl, Margaret T. Kasner, Donald E. Tsai, Dan T. Vogl, Alison W. Loren, Stephen J. Schuster, David L. Porter, Edward A. Stadtmauer, Steven C. Goldstein, Noelle V. Frey, Sunita D. Nasta, Elizabeth O. Hexner, Jamil K. Dierov, Cezary R. Swider, Adam Bagg, Alan M. Gewirtz, Martin Carroll, Selina M. Luger
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (21): 6732–6739.
https://doi.org/10.1158/1078-0432.CCR-09-0842
Published: 02 November 2009
View articletitled, A Phase I Study of the Mammalian Target of Rapamycin Inhibitor Sirolimus and MEC Chemotherapy in Relapsed and Refractory Acute Myelogenous Leukemia
Open the PDF for A Phase I Study of the Mammalian Target of Rapamycin Inhibitor Sirolimus and MEC Chemotherapy in Relapsed and Refractory Acute Myelogenous Leukemia in another window